IL320461A - שיטות לאיתור -mtbr csf טאו ושימושים בו - Google Patents

שיטות לאיתור -mtbr csf טאו ושימושים בו

Info

Publication number
IL320461A
IL320461A IL320461A IL32046125A IL320461A IL 320461 A IL320461 A IL 320461A IL 320461 A IL320461 A IL 320461A IL 32046125 A IL32046125 A IL 32046125A IL 320461 A IL320461 A IL 320461A
Authority
IL
Israel
Prior art keywords
mtbr
tau
methods
detect csf
csf
Prior art date
Application number
IL320461A
Other languages
English (en)
Original Assignee
Washington University St Louis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Washington University St Louis filed Critical Washington University St Louis
Publication of IL320461A publication Critical patent/IL320461A/he

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711Alzheimer's disease; Amyloid plaque core protein
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/62Detectors specially adapted therefor
    • G01N30/72Mass spectrometers
    • G01N30/7233Mass spectrometers interfaced to liquid or supercritical fluid chromatograph
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875Nucleoproteins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in epitope analysis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/948Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433Serine endopeptidases (3.4.21)
    • G01N2333/96441Serine endopeptidases (3.4.21) with definite EC number

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL320461A 2022-11-14 2023-11-14 שיטות לאיתור -mtbr csf טאו ושימושים בו IL320461A (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263425242P 2022-11-14 2022-11-14
PCT/US2023/079668 WO2024107745A1 (en) 2022-11-14 2023-11-14 Methods to detect csf mtbr-tau and uses thereof

Publications (1)

Publication Number Publication Date
IL320461A true IL320461A (he) 2025-06-01

Family

ID=91085398

Family Applications (1)

Application Number Title Priority Date Filing Date
IL320461A IL320461A (he) 2022-11-14 2023-11-14 שיטות לאיתור -mtbr csf טאו ושימושים בו

Country Status (12)

Country Link
EP (1) EP4619416A1 (he)
JP (1) JP2025539261A (he)
KR (1) KR20250109226A (he)
CN (1) CN120500495A (he)
AU (1) AU2023379437A1 (he)
CL (1) CL2025001424A1 (he)
CO (1) CO2025006348A2 (he)
CR (1) CR20250208A (he)
IL (1) IL320461A (he)
MX (1) MX2025005517A (he)
PE (1) PE20251700A1 (he)
WO (1) WO2024107745A1 (he)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014011972A1 (en) * 2012-07-13 2014-01-16 Bristol-Myers Squibb Company Tau immunoassay
KR102770650B1 (ko) * 2015-07-06 2025-02-19 유씨비 바이오파마 에스알엘 타우 결합 항체
EP4013772A4 (en) * 2019-08-13 2024-06-05 Washington University METHODS FOR DETECTING MTBR-TAU ISOFORMS AND THEIR USE

Also Published As

Publication number Publication date
CN120500495A (zh) 2025-08-15
WO2024107745A1 (en) 2024-05-23
AU2023379437A1 (en) 2025-05-08
CR20250208A (es) 2025-08-04
CO2025006348A2 (es) 2025-06-16
MX2025005517A (es) 2025-06-02
CL2025001424A1 (es) 2025-09-05
EP4619416A1 (en) 2025-09-24
PE20251700A1 (es) 2025-07-02
KR20250109226A (ko) 2025-07-16
JP2025539261A (ja) 2025-12-04

Similar Documents

Publication Publication Date Title
GB2581872B (en) Rack easy to assemble and disassemble
EP3221813A4 (en) Methods relating to the detection of recurrent and non-specific double strand breaks in the genome
HRP20180307T1 (hr) Novi mutanti prongf-a i njihova upotreba u proizvodnji beta-ngf-a
WO2013090228A3 (en) Maesa japonica extracts and methods of use
IL284886A (he) הרכבה של חלקים של חיישנים ושיטות שימוש
SG11202010393PA (en) Bioreactor with freeze-thaw capabilities to enhance product recovery and related methods
PT2951286T (pt) Microrganismos recombinantes que compreedem enzimas dependentes de nadph e métodos de produção dos mesmos
EP3265988A4 (en) Skimming to and past points of interest in digital content
GB2633285B (en) Improvements in or relating to methods of sensing
IL320461A (he) שיטות לאיתור -mtbr csf טאו ושימושים בו
CA3271912A1 (en) Methods to detect csf mtbr-tau and uses thereof
GB201215114D0 (en) Improvements in or relating to the processing of noisy analogue signals
GB201122146D0 (en) Screening methods to identify compounds useful in the prevention and/or treatment of inflammatory conditions
GB2582626B (en) Improvements in and relating to tyres
GB201911939D0 (en) Improvements in and relating to contruction
GB202010371D0 (en) Methods and uses relating to proteins
GB201708096D0 (en) Improvements in and relating to acoustic panels
GB201908488D0 (en) Improvements in and relating to the production of vinyl records
GB201904376D0 (en) Improvements in or relating to a method of separating and amalysing a component
GB202112662D0 (en) Improvements in or relating to devices and methods
GB202111709D0 (en) Improvements in or relating to devices and methods
GB201916497D0 (en) Improvements in or relating to devices and methods
GB202308562D0 (en) Novel methods and uses
GB2582538B (en) Improvements in and relating to testing
GB202316080D0 (en) Improvements in or relating to devices and methods